University of Colorado Boulder

About: University of Colorado Boulder is a education organization based out in Boulder, Colorado, United States. It is known for research contribution in the topics: Population & Galaxy. The organization has 48794 authors who have published 115151 publications receiving 5387328 citations. The organization is also known as: CU Boulder & UCB.

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Abstract: BACKGROUND The most appropriate targets for systolic blood pressure to reduce cardiovascular morbidity and mortality among persons without diabetes remain uncertain. METHODS We randomly assigned 9361 persons with a systolic blood pressure of 130 mm Hg or higher and an increased cardiovascular risk, but without diabetes, to a systolic blood-pressure target of less than 120 mm Hg (intensive treatment) or a target of less than 140 mm Hg (standard treatment). The primary composite outcome was myocardial infarction, other acute coronary syndromes, stroke, heart failure, or death from cardiovascular causes. RESULTS At 1 year, the mean systolic blood pressure was 121.4 mm Hg in the intensive-treatment group and 136.2 mm Hg in the standard-treatment group. The intervention was stopped early after a median follow-up of 3.26 years owing to a significantly lower rate of the primary composite outcome in the intensive-treatment group than in the standard-treatment group (1.65% per year vs. 2.19% per year; hazard ratio with intensive treatment, 0.75; 95% confidence interval [CI], 0.64 to 0.89; P<0.001). All-cause mortality was also significantly lower in the intensive-treatment group (hazard ratio, 0.73; 95% CI, 0.60 to 0.90; P=0.003). Rates of serious adverse events of hypotension, syncope, electrolyte abnormalities, and acute kidney injury or failure, but not of injurious falls, were higher in the intensive-treatment group than in the standard-treatment group. CONCLUSIONS Among patients at high risk for cardiovascular events but without diabetes, targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, resulted in lower rates of fatal and nonfatal major cardiovascular events and death from any cause, although significantly higher rates of some adverse events were observed in the intensive-treatment group. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT01206062.).

Pin: building customized program analysis tools with dynamic instrumentation

Abstract: Robust and powerful software instrumentation tools are essential for program analysis tasks such as profiling, performance evaluation, and bug detection. To meet this need, we have developed a new instrumentation system called Pin. Our goals are to provide easy-to-use, portable, transparent, and efficient instrumentation. Instrumentation tools (called Pintools) are written in C/C++ using Pin's rich API. Pin follows the model of ATOM, allowing the tool writer to analyze an application at the instruction level without the need for detailed knowledge of the underlying instruction set. The API is designed to be architecture independent whenever possible, making Pintools source compatible across different architectures. However, a Pintool can access architecture-specific details when necessary. Instrumentation with Pin is mostly transparent as the application and Pintool observe the application's original, uninstrumented behavior. Pin uses dynamic compilation to instrument executables while they are running. For efficiency, Pin uses several techniques, including inlining, register re-allocation, liveness analysis, and instruction scheduling to optimize instrumentation. This fully automated approach delivers significantly better instrumentation performance than similar tools. For example, Pin is 3.3x faster than Valgrind and 2x faster than DynamoRIO for basic-block counting. To illustrate Pin's versatility, we describe two Pintools in daily use to analyze production software. Pin is publicly available for Linux platforms on four architectures: IA32 (32-bit x86), EM64T (64-bit x86), Itanium®, and ARM. In the ten months since Pin 2 was released in July 2004, there have been over 3000 downloads from its website.

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

Abstract: The two primary human inflammatory bowel diseases, Crohn's disease (CD) and ulcerative colitis (UC), are idiopathic relapsing disorders characterized by chronic inflammation of the intestinal tract. Although several lines of reasoning suggest that gastrointestinal (GI) microbes influence inflammatory bowel disease (IBD) pathogenesis, the types of microbes involved have not been adequately described. Here we report the results of a culture-independent rRNA sequence analysis of GI tissue samples obtained from CD and UC patients, as well as non-IBD controls. Specimens were obtained through surgery from a variety of intestinal sites and included both pathologically normal and abnormal states. Our results provide comprehensive molecular-based analysis of the microbiota of the human small intestine. Comparison of clone libraries reveals statistically significant differences between the microbiotas of CD and UC patients and those of non-IBD controls. Significantly, our results indicate that a subset of CD and UC samples contained abnormal GI microbiotas, characterized by depletion of commensal bacteria, notably members of the phyla Firmicutes and Bacteroidetes. Patient stratification by GI microbiota provides further evidence that CD represents a spectrum of disease states and suggests that treatment of some forms of IBD may be facilitated by redress of the detected microbiological imbalances.